Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Head and Neck Cancer

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 61 articles: HTML format Text format

Single Articles

April 2012
1. LAJER CB , Garnaes E, Friis-Hansen L, Norrild B, et al
   The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer.
   Br J Cancer. 2012 Apr 3. doi: 10.1038/bjc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
2. LAGERGREN J , Lindam A
   Increased risk of laryngeal and pharyngeal cancer after gastrectomy for ulcer disease in a population-based cohort study.
   Br J Cancer. 2012;106:1342-5.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2012
3. KOUKOURAKIS MI , Giatromanolaki A, Tsakmaki V, Danielidis V, et al
   Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer.
   Br J Cancer. 2012;106:846-53.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. HIRASHIMA K , Baba Y, Watanabe M, Karashima RI, et al
   Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma.
   Br J Cancer. 2012;106:876-82.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. MIYAGAKI H , Yamasaki M, Miyata H, Takahashi T, et al
   Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma.
   Br J Cancer. 2012;106:947-54.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. KELLY P , Paulin F, Lamont D, Baker L, et al
   Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.
   Br J Cancer. 2012;106:955-61.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. ETTL T , Baader K, Stiegler C, Muller M, et al
   Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer.
   Br J Cancer. 2012;106:719-26.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. DUTTA S , Going JJ, Crumley AB, Mohammed Z, et al
   The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma.
   Br J Cancer. 2012;106:702-10.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. NYHAN MJ , O'Donovan TR, Elzinga B, Crowley LC, et al
   The BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells.
   Br J Cancer. 2012;106:711-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. MASEKI S , Ijichi K, Tanaka H, Fujii M, et al
    Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3beta/snail signalling pathway.
    Br J Cancer. 2012 Feb 7. doi: 10.1038/bjc.2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
11. KARGER S , Krause K, Gutknecht M, Schierle K, et al
    ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours.
    Br J Cancer. 2012;106:562-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. KURASHIGE J , Watanabe M, Iwatsuki M, Kinoshita K, et al
    Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma.
    Br J Cancer. 2012;106:182-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
13. JUNOR E , Kerr G, Oniscu A, Campbell S, et al
    Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx.
    Br J Cancer. 2011 Dec 6. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
14. GREEN J , Roddam A, Pirie K, Kirichek O, et al
    Reproductive factors and risk of oesophageal and gastric cancer in the Million Women Study cohort.
    Br J Cancer. 2011 Nov 29. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. ERLICH RB , Kherrouche Z, Rickwood D, Endo-Munoz L, et al
    Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma.
    Br J Cancer. 2011 Nov 24. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. CHANG CM , Yu KJ, Hsu WL, Major JM, et al
    Correlates of anti-EBV EBNA1 IgA positivity among unaffected relatives from nasopharyngeal carcinoma multiplex families.
    Br J Cancer. 2011 Nov 17. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. KOLK A , Jubitz N, Mengele K, Mantwill K, et al
    Expression of Y-box-binding protein YB-1 allows stratification into long- and short-term survivors of head and neck cancer patients.
    Br J Cancer. 2011 Nov 17. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. COLLEY HE , Hearnden V, Jones AV, Weinreb PH, et al
    Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma.
    Br J Cancer. 2011;105:1582-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
19. NAGATA M , Nakayama H, Tanaka T, Yoshida R, et al
    Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma.
    Br J Cancer. 2011;105:1322-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. LI Q , Kawamura K, Okamoto S, Fujie H, et al
    Adenoviruses-mediated transduction of human oesophageal carcinoma cells with the interferon-lambda genes produced anti-tumour effects.
    Br J Cancer. 2011;105:1302-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. JOHNSON KJ , Carozza SE, Chow EJ, Fox EE, et al
    Birth characteristics and childhood carcinomas.
    Br J Cancer. 2011;105:1396-401.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
22. CHU CN , Chen SW, Bai LY, Mou CH, et al
    Increase in stroke risk in patients with head and neck cancer: a retrospective cohort study.
    Br J Cancer. 2011 Sep 13. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. REID TD , Sanyaolu LN, Chan D, Williams GT, et al
    Relative prognostic value of TNM7 vs TNM6 in staging oesophageal cancer.
    Br J Cancer. 2011;105:842-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. WAINBERG ZA , Lin LS, DiCarlo B, Dao KM, et al
    Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction.
    Br J Cancer. 2011;105:760-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
25. CROUCHER R , Islam SS, Nunn H
    Campaign awareness and oral cancer knowledge in UK resident adult Bangladeshi: a cross-sectional study.
    Br J Cancer. 2011 Aug 23. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. DEL CAMPO JM , Hitt R, Sebastian P, Carracedo C, et al
    Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck.
    Br J Cancer. 2011 Aug 9. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
27. DEN HOED CM , van Blankenstein M, Dees J, Kuipers EJ, et al
    The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma.
    Br J Cancer. 2011;105:200-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
28. KOMATSU S , Ichikawa D, Takeshita H, Tsujiura M, et al
    Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.
    Br J Cancer. 2011;105:104-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. TVERDAL A , Hjellvik V, Selmer R
    Coffee intake and oral-oesophageal cancer: follow-up of 389,624 Norwegian men and women 40-45 years.
    Br J Cancer. 2011;105:157-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. ANDERSON KS , Wong J, D'Souza G, Riemer AB, et al
    Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer.
    Br J Cancer. 2011;104:1896-905.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. BOCKELMAN C , Hagstrom J, Makinen LK, Keski-Santti H, et al
    High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer.
    Br J Cancer. 2011;104:1890-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. FIELDS RC , Strong VE, Gonen M, Goodman KA, et al
    Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma.
    Br J Cancer. 2011;104:1840-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
33. VERMORKEN JB , Guigay J, Mesia R, Trigo JM, et al
    Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part.
    Br J Cancer. 2011;104:1691-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
34. BAUERNHOFER T , Pichler M, Wieckowski E, Stanson J, et al
    Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. HAKIM M , Billan S, Tisch U, Peng G, et al
    Diagnosis of head-and-neck cancer from exhaled breath.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
36. FRIEDLAND PL , Bozic B, Dewar J, Kuan R, et al
    Impact of multidisciplinary team management in head and neck cancer patients.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. GEE HE , Buffa FM, Camps C, Ramachandran A, et al
    The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis.
    Br J Cancer. 2011;104:1168-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. CHALLEN C , Brown H, Cai C, Betts G, et al
    Mitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. HORIKAWA T , Yoshizaki T, Kondo S, Furukawa M, et al
    Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. LAJER CB , Nielsen FC, Friis-Hansen L, Norrild B, et al
    Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study.
    Br J Cancer. 2011;104:830-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. WONG VC , Ko JM, Qi RZ, Li PJ, et al
    Abrogated expression of DEC1 during oesophageal squamous cell carcinoma progression is age- and family history-related and significantly associated with lymph node metastasis.
    Br J Cancer. 2011;104:841-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. KUROSU T , Ohga N, Hida Y, Maishi N, et al
    HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium.
    Br J Cancer. 2011;104:819-29.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
43. YAMASAKI M , Makino T, Masuzawa T, Kurokawa Y, et al
    Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma.
    Br J Cancer. 2011;104:707-13.
    PubMed     Text format     Related articles   
    
    
    
    
44. MICHIKAWA C , Uzawa N, Sato H, Ohyama Y, et al
    Epidermal growth factor receptor gene copy number aberration at the primary tumour is significantly associated with extracapsular spread in oral cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. HOCKING JS , Stein A, Conway EL, Regan D, et al
    Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. DE VITA F , Orditura M, Martinelli E, Vecchione L, et al
    A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer.
    Br J Cancer. 2011;104:427-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. NG LK , Rich AM, Hussaini HM, Thomson WM, et al
    Toll-like receptor 2 is present in the microenvironment of oral squamous cell carcinoma.
    Br J Cancer. 2011;104:460-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
48. DAY FL , Leong T, Ngan S, Thomas R, et al
    Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer.
    Br J Cancer. 2011;104:265-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. ZABLOTSKA LB , Ron E, Rozhko AV, Hatch M, et al
    Thyroid cancer risk in Belarus among children and adolescents exposed to radioiodine after the Chornobyl accident.
    Br J Cancer. 2011;104:181-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
50. SCHACHE AG , Hall G, Woolgar JA, Nikolaidis G, et al
    Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma.
    Br J Cancer. 2010;103:1846-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
51. KORNFELD JW , Meder S, Wohlberg M, Friedrich RE, et al
    Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. ARAKI K , Yamashita T, Reddy N, Wang H, et al
    Molecular disruption of NBS1 with targeted gene delivery enhances chemosensitisation in head and neck cancer.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. HONG AM , Dobbins TA, Lee CS, Jones D, et al
    Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy.
    Br J Cancer. 2010;103:1510-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
54. CONROY T , Yataghene Y, Etienne PL, Michel P, et al
    Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer.
    Br J Cancer. 2010;103:1349-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. BRADLEY G , Odell EW, Raphael S, Ho J, et al
    Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma.
    Br J Cancer. 2010;103:1432-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
56. KESSELRING R , Thiel A, Pries R, Trenkle T, et al
    Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. DE VATHAIRE F , Drozdovitch V, Brindel P, Rachedi F, et al
    Thyroid cancer following nuclear tests in French Polynesia.
    Br J Cancer. 2010;103:1115-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. HE Z , Zhao Y, Guo C, Liu Y, et al
    Prevalence and risk factors for esophageal squamous cell cancer and precursor lesions in Anyang, China: a population-based endoscopic survey.
    Br J Cancer. 2010;103:1085-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. LEE S , Park YH, Kim KH, Cho EY, et al
    Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell ca
    Br J Cancer. 2010;103:845-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. KIKKAWA N , Hanazawa T, Fujimura L, Nohata N, et al
    miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC).
    Br J Cancer. 2010;103:877-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
61. AMARASINGHE HK , Johnson NW, Lalloo R, Kumaraarachchi M, et al
    Derivation and validation of a risk-factor model for detection of oral potentially malignant disorders in populations with high prevalence.
    Br J Cancer. 2010;103:303-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: